These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 38339335)

  • 1. Hypoxic Signaling Pathways in Carotid Body Tumors.
    Cao K; Yuan W; Hou C; Wang Z; Yu J; Wang T
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiopathogenesis and clinical presentation of carotid body tumors.
    Baysal BE; Myers EN
    Microsc Res Tech; 2002 Nov; 59(3):256-61. PubMed ID: 12384970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas.
    Merlo A; de Quiros SB; Secades P; Zambrano I; Balbín M; Astudillo A; Scola B; Arístegui M; Suarez C; Chiara MD
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2194-200. PubMed ID: 22977270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, characteristics, evaluation, and management of carotid body tumors: Systematic analysis based on available evidence.
    Wang YH; Yang J; Zhong H; Wu JJ; Wu K; Hu A; Wu JY; Zhu JH
    J Vasc Surg; 2024 Aug; 80(2):574-585.e4. PubMed ID: 38580159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate.
    Merlo A; Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Pitiot AS; Balbín M; Astudillo A; Valdés N; Scola B; Del Toro R; Méndez-Ferrer S; Piruat JI; Suarez C; Chiara MD
    Oncotarget; 2017 Jan; 8(4):6700-6717. PubMed ID: 28036268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carotid body paraganglioma metastatic to spine causing cord compression: a case report.
    Tabb JN; Maas JA; Earla BP; Fallon KB; McDonald AM; Dobelbower MC
    Diagn Pathol; 2023 Feb; 18(1):31. PubMed ID: 36829189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research advances in molecular biology of carotid body tumor].
    Zhou Q; Zheng JW
    Shanghai Kou Qiang Yi Xue; 2009 Apr; 18(2):218-22. PubMed ID: 19418004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific prognosis of mutation-positive patients with head and neck paragangliomas.
    Sen I; Young WF; Kasperbauer JL; Polonis K; Harmsen WS; Colglazier JJ; DeMartino RR; Oderich GS; Kalra M; Bower TC
    J Vasc Surg; 2020 May; 71(5):1602-1612.e2. PubMed ID: 32035780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma.
    Wang Y; Liu B; Li F; Zhang Y; Gao X; Wang Y; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1274239. PubMed ID: 37867526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential HIF2α Protein Expression in Human Carotid Body and Adrenal Medulla under Physiologic and Tumorigenic Conditions.
    Celada L; Cubiella T; San-Juan-Guardado J; San José Martínez A; Valdés N; Jiménez-Fonseca P; Díaz I; Enguita JM; Astudillo A; Álvarez-González E; Sierra LM; Chiara MD
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
    Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Outcomes in Carotid Body Tumors Treatment: The Impact of a Multidisciplinary Team Approach.
    Menegolo M; Xodo A; Bozza R; Piazza M; Pirri C; Caroccia B; Schiavi F; Opocher G; Antonello M; Grego F
    Ann Vasc Surg; 2021 Aug; 75():315-323. PubMed ID: 33556521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.
    Gaal J; Burnichon N; Korpershoek E; Roncelin I; Bertherat J; Plouin PF; de Krijger RR; Gimenez-Roqueplo AP; Dinjens WN
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1274-8. PubMed ID: 19915015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
    Baysal BE; Maher ER
    Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar gene expression profiles of sporadic, PGL2-, and SDHD-linked paragangliomas suggest a common pathway to tumorigenesis.
    Hensen EF; Goeman JJ; Oosting J; Van der Mey AG; Hogendoorn PC; Cremers CW; Devilee P; Cornelisse CJ
    BMC Med Genomics; 2009 May; 2():25. PubMed ID: 19432956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription association of VHL and SDH mutations link hypoxia and oxidoreductase signals in pheochromocytomas.
    Dahia PL;
    Ann N Y Acad Sci; 2006 Aug; 1073():208-20. PubMed ID: 17102089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of SDHB is a cause of hypoxia-related high-altitude paraganglioma.
    Cerecer-Gil NY; Figuera LE; Llamas FJ; Lara M; Escamilla JG; Ramos R; Estrada G; Hussain AK; Gaal J; Korpershoek E; de Krijger RR; Dinjens WN; Devilee P; Bayley JP
    Clin Cancer Res; 2010 Aug; 16(16):4148-54. PubMed ID: 20592014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current surgical management of carotid body tumors.
    Davila VJ; Chang JM; Stone WM; Fowl RJ; Bower TC; Hinni ML; Money SR
    J Vasc Surg; 2016 Dec; 64(6):1703-1710. PubMed ID: 27871494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
    Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
    Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SDHA is a tumor suppressor gene causing paraganglioma.
    Burnichon N; Brière JJ; Libé R; Vescovo L; Rivière J; Tissier F; Jouanno E; Jeunemaitre X; Bénit P; Tzagoloff A; Rustin P; Bertherat J; Favier J; Gimenez-Roqueplo AP
    Hum Mol Genet; 2010 Aug; 19(15):3011-20. PubMed ID: 20484225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.